Answers are grounded in this paper and cite their sources.
In Portugal erythromycin resistance of 26.6% (n = 352) remained constant during 1998 to 2003, however in 1998 the MLS(B) phenotype dominated (85%), whereas in 2003 the M phenotype prevailed (77%). A decline in T12/emm22 MLS(B) isolates could partially explain the drop in this phenotype, but the rise of the M phenotype was not due to clonal expansion.
No takes yet. Share an insight, caveat, or question.
Silva‐Costa et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: